Stay updated on Nanogold for Remyelination in MS Clinical Trial
Sign up to get notified when there's something new on the Nanogold for Remyelination in MS Clinical Trial page.

Latest updates to the Nanogold for Remyelination in MS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page history shows a new entry Revision: v3.3.3 and removals of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page footer now shows Revision: v3.3.2 and no longer shows Revision: v3.2.0, reflecting a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved a site-wide government funding and operating status notice; core study history and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check63 days agoChange DetectedOnly cosmetic/UI changes are visible (layout spacing and header/footer styling); core content, study history entries, and statuses remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange Detected- Updated operating-status notice and new version v3.2.0; removed v3.1.0. The page now references current status information and the latest release.SummaryDifference12%

- Check98 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Nanogold for Remyelination in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nanogold for Remyelination in MS Clinical Trial page.